RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$913M
AUM Growth
+$115M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
108
New
Increased
Reduced
Closed

Top Buys

1
+$9.4M
2
+$9.14M
3
+$7.09M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.8M
5
COO icon
Cooper Companies
COO
+$6.43M

Top Sells

1
+$12.1M
2
+$12M
3
+$11.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$11.1M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.05M

Sector Composition

1 Healthcare 93.54%
2 Financials 0.09%
3 Energy 0.09%
4 Technology 0.09%
5 Communication Services 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$39.4M 4.31%
660,000
+4,146
2
$35M 3.84%
160,000
-26,000
3
$29.5M 3.23%
350,000
+10,000
4
$28.1M 3.07%
775,000
-250,000
5
$24.6M 2.69%
67,000
+7,000
6
$23.7M 2.6%
73,333
-6,667
7
$21.8M 2.39%
340,000
-75,000
8
$20.4M 2.24%
451,668
+81,668
9
$19.4M 2.13%
95,000
+15,000
10
$18.7M 2.05%
62,000
+2,000
11
$18.6M 2.04%
210,000
+40,000
12
$18M 1.97%
207,469
-12,645
13
$17.8M 1.95%
210,000
-80,491
14
$17.2M 1.88%
500,000
-350,000
15
$17.1M 1.87%
58,000
-19,000
16
$16.9M 1.85%
700,000
+225,000
17
$16.1M 1.77%
125,000
+25,000
18
$15.3M 1.68%
210,000
+10,000
19
$15.3M 1.67%
141,319
-105,984
20
$15.1M 1.65%
200,000
+80,000
21
$15M 1.65%
100,805
-49,195
22
$14.8M 1.63%
87,000
-33,000
23
$14.8M 1.62%
700,000
-150,000
24
$14.6M 1.61%
111,446
-38,554
25
$14.6M 1.59%
167,680
-57,640
1
2 3 4 5